^„Human PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
^„Mouse PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
^Spicer AP, Seldin MF, Olsen AS, Brown N, Wells DE, Doggett NA, Itano N, Kimata K, Inazawa J, McDonald JA (јул 1997). „Chromosomal localization of the human and mouse hyaluronan synthase genes”. Genomics. 41 (3): 493—7. PMID9169154. doi:10.1006/geno.1997.4696.CS1 одржавање: Формат датума (веза)
Itano N, Kimata K (1996). „Molecular cloning of human hyaluronan synthase.”. Biochem. Biophys. Res. Commun. 222 (3): 816—20. PMID8651928. doi:10.1006/bbrc.1996.0827.
Shyjan AM, Heldin P, Butcher EC, et al. (1996). „Functional cloning of the cDNA for a human hyaluronan synthase.”. J. Biol. Chem. 271 (38): 23395—9. PMID8798544. doi:10.1074/jbc.271.38.23395.
Simpson MA, Wilson CM, Furcht LT, et al. (2002). „Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells.”. J. Biol. Chem. 277 (12): 10050—7. PMID11790779. doi:10.1074/jbc.M110069200.
Calabro A, Oken MM, Hascall VC, Masellis AM (2002). „Characterization of hyaluronan synthase expression and hyaluronan synthesis in bone marrow mesenchymal progenitor cells: predominant expression of HAS1 mRNA and up-regulated hyaluronan synthesis in bone marrow cells derived from multiple myeloma patients.”. Blood. 100 (7): 2578—85. PMID12239172. doi:10.1182/blood-2002-01-0030.
Suzuki K, Yamamoto T, Usui T, et al. (2004). „Expression of hyaluronan synthase in intraocular proliferative diseases: regulation of expression in human vascular endothelial cells by transforming growth factor-beta.”. Jpn. J. Ophthalmol. 47 (6): 557—64. PMID14636845. doi:10.1016/j.jjo.2003.09.001.
Yabushita H, Kishida T, Fusano K, et al. (2005). „Role of hyaluronan and hyaluronan synthase in endometrial cancer.”. Oncol. Rep. 13 (6): 1101—5. PMID15870928. doi:10.3892/or.13.6.1101.
Stuhlmeier KM, Pollaschek C (2006). „Adenovirus-mediated gene transfer of mutated IkappaB kinase and IkappaBalpha reveal NF-kappaB-dependent as well as NF-kappaB-independent pathways of HAS1 activation.”. J. Biol. Chem. 280 (52): 42766—73. PMID16258173. doi:10.1074/jbc.M503374200.
Grskovic B, Pollaschek C, Mueller MM, Stuhlmeier KM (2006). „Expression of hyaluronan synthase genes in umbilical cord blood stem/progenitor cells.”. Biochim. Biophys. Acta. 1760 (6): 890—5. PMID16564133. doi:10.1016/j.bbagen.2006.02.002.
Kao JJ (2007). „The NF-kappaB inhibitor pyrrolidine dithiocarbamate blocks IL-1beta induced hyaluronan synthase 1 (HAS1) mRNA transcription, pointing at NF-kappaB dependence of the gene HAS1.”. Exp. Gerontol. 41 (6): 641—7. PMID16723203. S2CID54406345. doi:10.1016/j.exger.2006.04.003.
Campo GM, Avenoso A, Campo S, et al. (2007). „TNF-alpha, IFN-gamma, and IL-1beta modulate hyaluronan synthase expression in human skin fibroblasts: synergistic effect by concomital treatment with FeSO4 plus ascorbate.”. Mol. Cell. Biochem. 292 (1–2): 169—78. PMID16786194. S2CID37598580. doi:10.1007/s11010-006-9230-7.
Meran S, Thomas D, Stephens P, et al. (2007). „Involvement of hyaluronan in regulation of fibroblast phenotype.”. J. Biol. Chem. 282 (35): 25687—97. PMID17611197. doi:10.1074/jbc.M700773200.
Kyossev Z, Weigel PH (2007). „An enzyme capture assay for analysis of active hyaluronan synthases.”. Anal. Biochem. 371 (1): 62—70. PMID17904513. doi:10.1016/j.ab.2007.08.025.